Kulwinder S. Dua

Kulwinder S. Dua

Auto-generated profile, based on publicly available information

Kulwinder S. Dua

Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI, USA

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 February 2012 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
PBPetra Ga van Boeckel
Petra Ga van Boeckel
KDKulwinder S Dua
Kulwinder S Dua
BWBas Lam Weusten
Bas Lam Weusten
RSRuben Jh Schmits
Ruben Jh Schmits
NSNaveen Surapaneni
Naveen Surapaneni
PSPeter D Siersema
Peter D Siersema
Benign esophageal ruptures and anastomotic leaks are life-threatening conditions that are often treated surgically. Recently, placement of partially and fully covered metal or plastic stents has emerged as a minimally invasive treatment option. We aimed to determine the clinical effectiveness of covered stent placement for the treatment of esophageal ruptures and anastomotic leaks with special emphasis on different stent designs.

1 October 2012 in Clinical and Translational Gastroenterology
Verified
Journal Article
Open access
SMSaurabh Mukewar
Saurabh Mukewar
SMShrikant Mukewar
Shrikant Mukewar
RRRaghvendra Ravi
Raghvendra Ravi
APArun Prasad
Arun Prasad
KDKulwinder S Dua
Kulwinder S Dua
Studies looking at the outcomes of colon lesions, especially after anti-TB treatment. Our aim was to evaluate the endoscopic features of TB of the colon and to prospectively follow up the endoscopic response of colon lesions to anti-TB treatment. METHODS: From October 2004 to December 2010 consecutive patients presenting with colon TB to one tertiary care center in India were enrolled. Demographic, clinical data, and lesions identified on colonoscopy were recorded. Anti-TB treatment was started and follow-up colonoscopy was performed within 4 weeks after completion of anti-TB treatment. Post-treatment endoscopic features and clinical outcomes were noted. RESULTS: Sixty-nine consecutive patients with colon TB were enrolled (mean age 39.3±14.8 years; male 45, female 24). Presenting clinical features included abdominal pain 80.6%, weight loss 74.6%, fever 40.3%, diarrhea/constipation 25.4%, diarrhea 16.4%, blood per rectum 11.9%, abdominal tenderness 37.3%, abdominal mass 13.4%, and lymphadenopathy 1.5%. Macroscopic lesions on endoscopy were predominantly right-sided (cecum and ascending colon) and primarily ulcers (ulcers 88.0%, nodules 50.7%, luminal narrowing 44.8%, polypoid lesion 10.4%). Majority of the ulcers (87.2%), nodules (84.6%), polypoid lesions (85.7%), luminal narrowing (76.2%), and ileo-cecal valve deformities (76.5%) resolved with anti-TB treatment. CONCLUSIONS: TB of the colon predominantly affects the cecum and the ascending colon. Ulceration, nodularity, and stricture are the prominent endoscopic findings. Majority of the lesions heal with anti-TB treatment. *Correspondence: KS Dua, MD, DMSc, FRCP (Edinburgh), FACP, FRCP (London), FASGE, Professor of Medicine, Division of Gastroenterology and Hepatology, Medical College of Wisconsin, 9200, West Wisconsin Avenue, Milwaukee, Wisconsin 53226, USA. E-mail: kdua@mcw.edu Received 9 March 12; revised 26 June 12; accepted 30 July 12 published online 11 October 2012 Part of this work was presented at the Digestive Disease Week, 2007. © 2012 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology...

1 July 2016 in The Lancet
Verified
Journal Article
Closed access
KDKulwinder S Dua
Kulwinder S Dua
WHWalter J Hogan
Walter J Hogan
AAAbdul A Aadam
Abdul A Aadam
MGMario Gasparri
Mario Gasparri

1 February 2018 in Current Gastroenterology Reports
Verified
Journal Article
Closed access
PDF file
MAMurad Aburajab
Murad Aburajab
KDKulwinder Dua
Kulwinder Dua

1 January 2002 in Dysphagia
Verified
Journal Article
Closed access
PDF file
RSReza Shaker
Reza Shaker
KDKulwinder S. Dua
Kulwinder S. Dua
JRJunlong Ren
Junlong Ren
PXPengyan Xie
Pengyan Xie
AFAkira Funahashi
Akira Funahashi
RSRalph M. Schapira
Ralph M. Schapira

1 September 2016 in Journal of Oncology Practice
Verified
Journal Article
Open access
STSusan Tsai
Susan Tsai
BEBeth A. Erickson
Beth A. Erickson
KDKulwinder Dua
Kulwinder Dua
PRPaul S. Ritch
Paul S. Ritch
PTParag Tolat
Parag Tolat
DEDouglas B. Evans
Douglas B. Evans
In pancreatic cancer, as with many other solid tumors, a commonly held surgical adage—a chance to cut is a chance to cure—has been promulgated throughout the years. Following such reasoning, surgical extirpation of a localized tumor would prevent tumor dissemination and metastatic tumor progression. However, decades of surgical experience have demonstrated that surgical resection alone provides a limited median survival benefit. Despite the optimization of surgical technique and perioperative management over the past three decades, little progress has been made to improve the limited survival of patients with localized pancreatic cancer who receive surgery. In this article, we discuss the rationale for a novel management strategy for patients with resectable pancreatic cancer, which may improve patient selection and the delivery of multimodality therapy.